Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes

Nonalcoholic fatty liver disease (NAFLD) is a group of obesity-associated pathological changes characterized by abnormal accumulation of lipids in cells of the liver parenchyma. NAFLD and associated conditions, namely insulin resistance and type II diabetes mellitus (DM2), as well as the possible ri...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Apollinariya V. Bogolyubova, Alexander Y. Mayorov, Ekaterina E. Mishina, Anton M. Schwartz, Pavel V. Belousov
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2017
Materias:
Acceso en línea:https://doaj.org/article/d30df532fce74d6d8dfcbb518f2a4ae4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!